BioAesthetics, founded in 2015 as a spin-out from Tulane University, aims to enhance breast reconstruction options for breast cancer patients post-mastectomy. The company's core mission is to provide innovative, effective solutions for nipple reconstruction. Their flagship product, the NACgraft, is a tissue-engineered nipple-areolar complex designed to be an off-the-shelf, acellular graft for use by plastic and reconstructive surgeons during breast reconstruction procedures.
Notable individuals affiliated with BioAesthetics include experts in tissue engineering and reconstructive surgery. The company has garnered attention and support from investors focused on advancing medical technologies. Key achievements include the development and initial clinical use of the NACgraft, which has significantly impacted the quality of life for breast cancer survivors by offering a more natural and effective reconstruction option. BioAesthetics continues to push the boundaries of biomaterials to transform lives.
